{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:24:40Z","timestamp":1795091080829,"version":"4.10.2"},"reference-count":26,"publisher":"Tech Science Press","issue":"5","license":[{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":312,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJU"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/cju.2025.064564","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:45:33Z","timestamp":1751258733000},"page":"529-538","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between chronic prostate inflammation and overactive bladder symptoms following transurethral resection of the prostate due to benign prostate hyperplasia"],"prefix":"10.32604","volume":"32","author":[{"given":"Ozgu","family":"Aydogdu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Erdemoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil Ibrahim","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tansu","family":"Degirmenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1464-410X.2009.08850.x","article-title":"Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment","volume":"105","author":"He","year":"2010","journal-title":"BJU Int"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2012.08.088","article-title":"The prevalence and overlap of interstitial cystitis\/bladder pain syndrome and chronic prostatitis\/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study","volume":"189","author":"Suskind","year":"2013","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pros.24101","article-title":"Prostate-to-bladder cross-sensitization in a model of zymosan-induced chronic pelvic pain syndrome in rats","volume":"81","author":"Aydogdu","year":"2021","journal-title":"Prostate"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1113\/JP277452","article-title":"Bladder overactivity and afferent hyperexcitability induced by prostate-to-bladder cross-sensitization in rats with prostatic inflammation","volume":"597","author":"Funahashi","year":"2019","journal-title":"J Physiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12894-021-00882-9","article-title":"Cross-organ sensitization between the prostate and bladder in an experimental rat model of lipopolysaccharide (LPS)-induced chronic pelvic pain syndrome","volume":"21","author":"Aydogdu","year":"2021","journal-title":"BMC Urol"},{"key":"ref7","first-page":"18","article-title":"Men\u2019s health: benign prostatic hyperplasia","volume":"503","author":"Langan","year":"2021","journal-title":"FP Essent"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e21200017","DOI":"10.14440\/bladder.2024.0022","article-title":"Recent advances in the diagnosis of bladder outlet obstruction in men","volume":"11","author":"Li","year":"2024","journal-title":"Bladder"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/jpm12101675","article-title":"Bladder oversensitivity is associated with bladder outlet obstruction in men","volume":"12","author":"Verhovsky","year":"2022","journal-title":"J Pers Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/nau.20892","article-title":"Overactive bladder: is there a link to the metabolic syndrome in men?","volume":"29","author":"Kirby","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5694\/mja11.11318","article-title":"Overactive bladder in men as a marker of cardiometabolic risk","volume":"197","author":"Wittert","year":"2012","journal-title":"Med J Aust"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e14055","DOI":"10.1111\/and.14055","article-title":"Diagnosis of chronic prostatitis by noninvasive methods in elderly patients with benign prostatic hyperplasia in China","volume":"53","author":"Cao","year":"2021","journal-title":"Andrologia"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MOU.0000000000000369","article-title":"The role of prostatic inflammation in the development and progression of benign and malignant diseases","volume":"27","author":"Gandaglia","year":"2017","journal-title":"Curr Opin Urol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/iju.14122","article-title":"Tadalafil is sufficiently effective for severe chronic prostatitis\/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia","volume":"27","author":"Hiramatsu","year":"2020","journal-title":"Int J Urol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.prnil.2017.04.001","article-title":"Relation between histological prostatitis and lower urinary tract symptoms and erectile function","volume":"5","author":"Mizuno","year":"2017","journal-title":"Prostate Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.urology.2018.10.035","article-title":"From prostate health to overactive bladder: developing a crosswalk for the IPSS to OAB-V8","volume":"125","author":"Trafford Crump","year":"2019","journal-title":"Urology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00192-012-1921-x","article-title":"Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the overactive bladder 8-question awareness tool","volume":"24","author":"Villacampa","year":"2013","journal-title":"Int Urogynecol J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00345-020-03106-1","article-title":"Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia","volume":"38","author":"De Nunzio","year":"2020","journal-title":"World J Urol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0302-2838(02)00548-1","article-title":"Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis","volume":"43","author":"Di Silverio","year":"2003","journal-title":"Eur Urol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.juro.2015.03.103","article-title":"Prostate biopsy markers of inflammation are associated with risk of clinical progression of benign prostatic hyperplasia: findings from the MTOPS study","volume":"194","author":"Torkko","year":"2015","journal-title":"J Urol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","article-title":"Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia","volume":"84","author":"Nickel","year":"1999","journal-title":"BJU Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/end.2013.0022","article-title":"The effect of antibiotherapy on prostate-specific antigen levels and prostate biopsy results in patients with levels 2.5 to 10 ng\/mL","volume":"27","author":"Toktas","year":"2013","journal-title":"J Endourol"},{"key":"ref23","first-page":"185","article-title":"The effect of asymptomatic histological prostatitis on sexual function and lower urinary tract symptoms","volume":"69","author":"Urkmez","year":"2016","journal-title":"Arch Esp Urol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4111\/kju.2010.51.4.266","article-title":"The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment","volume":"51","author":"Kwon","year":"2010","journal-title":"Korean J Urol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5347(05)66541-X","article-title":"Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index","volume":"165","author":"Nickel","year":"2001","journal-title":"J Urol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.juro.2007.05.041","article-title":"Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial","volume":"178","author":"Nickel","year":"2007","journal-title":"J Urol"}],"container-title":["Canadian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/cju\/2025\/TSP_CJU-32-5\/TSP_CJU_64564\/TSP_CJU_64564.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:25:56Z","timestamp":1763346356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/CJU\/v32n5\/64366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/cju.2025.064564","relation":{},"ISSN":["1488-5581"],"issn-type":[{"value":"1488-5581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"2025-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-30","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}